L. Thomas

38.3k citations
402 papers · 14.0k · 4 hit papers · h-index 55

Impact in

  • Dermatology top 0.05%
    • Cutaneous lymphoproliferative disorders research
  • Oncology top 0.2%
    • Cutaneous Melanoma Detection and Management
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research

Papers in

    • Cutaneous Melanoma Detection and Management 110
    • CAR-T cell therapy research 23
    • Nonmelanoma Skin Cancer Studies 54
    • Nail Diseases and Treatments 40

L. Thomas

381 papers receiving 13.3k citations

L. Thomas's Hit Papers

Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial 2017 · 482 citations
4820+20+41Years since publication4008001.2k

Peers

L. Thomas
Comparison fields: 5 of 196
  • Dermatology 2.5k
  • Oncology 6.4k
  • Immunology 2.4k
  • Immunology and Allergy 522
  • Epidemiology 3.0k
Replace Timothy M. Johnson with:
Timothy M. Johnson United States
Jean‐Jacques Grob France
Arthur J. Sober United States
Kelly M. McMasters United States
Martin A. Weinstock United States
H. Peter Soyer Australia
Seng-Jaw Soong United States
Lars E. French Switzerland
Phyllis A. Gimotty United States
Alexander M.M. Eggermont Netherlands
L. Thomas relative to Timothy M. Johnson United States Timothy M. Johnson's profile →
Citations per field
00.5×1.5×1.8×
Timothy M. Johnson · 1×
Citations per year

Countries citing papers authored by L. Thomas

Since Specialization
Citations

This map shows the geographic impact of L. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Thomas more than expected).

Fields of papers citing papers by L. Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Thomas. The network helps show where L. Thomas may publish in the future.

Co-authors

The 25 scholars most cited alongside L. Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with L. Thomas Line = papers co-authored together L. Thomas links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 402 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma
Hit paper breakdown →
20141491
2
Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study
Hit paper breakdown →
2009934
3
Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial
Hit paper breakdown →
2017482
4
Delayed Hypersensitivity in vitro. I. The Specificity of Inhibition of Cell Migration by Antigens.
Hit paper breakdown →
1964387
5 2015373
6 1992289
7 1964268
8 1954243
9 2019198
10 2006185
11 2002175
12 2007171
13 2015170
14 2004157
15
Monoclonal antibody GB3 defines a widespread defect of several basement membranes and a keratinocyte dysfunction in patients with lethal junctional epidermolysis bullosa.
1991135
16 1981134
17 1998132
18 2011130
19 1999127
20 2021119

About L. Thomas

L. Thomas is a scholar working on Oncology, Epidemiology, Dermatology, Molecular Biology and Pathology and Forensic Medicine, having authored 402 papers that have together received 14.0k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (110 papers), Cutaneous lymphoproliferative disorders research (65 papers), Nonmelanoma Skin Cancer Studies (54 papers), Melanoma and MAPK Pathways (46 papers), Nail Diseases and Treatments (40 papers), CAR-T cell therapy research (23 papers), Cancer and Skin Lesions (21 papers) and Genetic and rare skin diseases. (20 papers). The work is most often cited by research in Dermatology (2.5k citations), Oncology (6.4k citations), Immunology (2.4k citations), Immunology and Allergy (522 citations) and Epidemiology (3.0k citations). L. Thomas has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Stéphane Dalle, B. Balme, H. Sherwood Lawrence, John R. David, Salah Al‐Askari, Jean‐Jacques Grob, Claus Garbe, Michele Maio, Alice Phan and Brigitte Dréno. Their work appears in journals such as British Journal of Dermatology, Dermatology, Journal of the European Academy of Dermatology and Venereology, Journal of Clinical Oncology and Clinical and Experimental Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact